[Trispecific broadly neutralizing antibodies for HIV immunoprophylaxis and immunotherapy?]

Med Sci (Paris). 2018 Feb;34(2):109-111. doi: 10.1051/medsci/20183402002. Epub 2018 Feb 16.

[Article in French]

Authors

Francis Barin¹, Karl Stefic¹

Affiliation

¹ Inserm U1259 et université François Rabelais, Centre national de référence du VIH, laboratoire de virologie, CHU Bretonneau, 2, boulevard Tonnellé, 37044 Tours Cedex, France.

PMID: 29451475
DOI: 10.1051/medsci/20183402002

No abstract available

Publication types

News

MeSH terms

Animals
Antibodies, Bispecific / physiology
Antibodies, Bispecific / therapeutic use*
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / therapeutic use
Antibodies, Neutralizing / therapeutic use*
Antibody Specificity / physiology*
Broadly Neutralizing Antibodies
Chemoprevention / methods*
HIV Antibodies / therapeutic use
HIV Envelope Protein gp120 / immunology
HIV Infections / prevention & control
HIV Infections / therapy*
HIV-1 / immunology
Humans
Immunotherapy / methods*
Vaccination / methods

Substances

Antibodies, Bispecific
Antibodies, Monoclonal
Antibodies, Neutralizing
Broadly Neutralizing Antibodies
HIV Antibodies
HIV Envelope Protein gp120
VRC01 monoclonal antibody
gp120 protein, Human immunodeficiency virus 1